Results 231 to 240 of about 25,687 (255)
Some of the next articles are maybe not open access.
La Revue du praticien
DRUG REPOSITIONING. Developing new therapeutic agents ("de novo") for human diseases is an increasingly lengthy and costly process, aimed at ensuring patient safety and drug efficacy. An alternative approach, drug repurposing or repositioning, involves using already commercialized or advanced molecules.
Clémence, Réda +2 more
openaire +1 more source
DRUG REPOSITIONING. Developing new therapeutic agents ("de novo") for human diseases is an increasingly lengthy and costly process, aimed at ensuring patient safety and drug efficacy. An alternative approach, drug repurposing or repositioning, involves using already commercialized or advanced molecules.
Clémence, Réda +2 more
openaire +1 more source
Biomedical data and computational models for drug repositioning: a comprehensive review
Briefings in Bioinformatics, 2021Huimin Luo +2 more
exaly
Deep learning in target prediction and drug repositioning: Recent advances and challenges
Drug Discovery Today, 2022Jun-Lin Yu, Guo-Bo Li
exaly
Structure-based drug repositioning: Potential and limits
Seminars in Cancer Biology, 2021Melissa F Adasme +2 more
exaly
COVID-19 drugs and drug repositioning
2021Introduction: The COVID-19 pandemic is caused by SARS-CoV-2. Drug repositioning is a propitious field in the development and discovery of therapeutic agents that distinguishes new therapeutic options for existing drugs. There are repositioned drugs in COVID-19 treatment. Aim: We aimed to explore repositioned drugs for COVID-19 pharmacotherapy.
openaire +1 more source
Drug repositioning: Progress and challenges in drug discovery for various diseases
European Journal of Medicinal Chemistry, 2022Xiaowen Dai, Haichun Liu, Yadong Chen
exaly
Topological network measures for drug repositioning
Briefings in Bioinformatics, 2021Apurva Badkas +2 more
exaly